BIIB Cash Flow Statement

Biogen Inc - Operating, Investing & Free Cash Flow Analysis

Operating Cash Flow

$2.88B

+85.9% YoY

Free Cash Flow

-

FCF per Share

-

CapEx

-

Operating Activities

Cash generated from core business operations

Net Cash from Operations

Primary cash generation

$2.88B
Net Income (Starting Point)$1.63B

Investing Activities

Cash used for investments and capital expenditures

Net Cash from Investing

Total investing activities

($799.20M)

Financing Activities

Cash from financing activities including debt, equity, and dividends

Net Cash from Financing

Total financing activities

($683.50M)

Free Cash Flow (FCF) Calculation

Operating Cash Flow$2.88B
- Capital Expenditures-
= Free Cash Flow-

Cash Flow Trends (Annual)

PeriodOperating CFInvesting CFFinancing CFFree CF
2024-12-31$2.88B($799.20M)($683.50M)-
2023-12-31$1.55B($4.10B)$149.30M-
2022-12-31$1.38B$1.58B($1.75B)-
2021-12-31$3.64B($563.70M)($2.09B)-
2020-12-31$4.23B($608.60M)($5.27B)-

View Complete Financial Analysis

Full income statements, balance sheets, and detailed cash flow analysis

Open Full Analysis

Frequently Asked Questions

What is BIIB free cash flow?

Free cash flow data for BIIB is available in the full cash flow statement.

What is BIIB operating cash flow?

BIIB generated $2.88B in operating cash flow in the most recent period. Operating cash flow shows the cash generated from core business operations.

What is BIIB FCF per share?

FCF per share can be calculated by dividing free cash flow by shares outstanding.

Is BIIB cash flow growing?

BIIB's operating cash flow grew by 85.9% year-over-year.

What is BIIB FCF yield?

FCF yield is calculated by dividing free cash flow by market capitalization.

What is BIIB capital expenditure?

Capital expenditure data is available in the investing activities section.

Explore Categories